P158 - Safety of once daily versus twice daily dosing with mesalazine (Pentasa®) sachets. Results from a 12 month randomised controlled trial in maintenance of remission of ulcerative colitis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.